Clinical Trials Logo

Clinical Trial Summary

This is A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison with Imipenem/Cilastatin/Relebactam in Adults with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05204563
Study type Interventional
Source Sinovent Pty Ltd.
Status Not yet recruiting
Phase Phase 3
Start date March 2022
Completion date December 2024